INFLECTION MEDICINE

diagnostic tests for detecting genetic diseases and disorders

development and commercialization of diagnostics for genetic diseases and disorders; development and commercialization of technology to improve clinical outcomes of individuals with genetic diseases and disorders; development and commercialization of diagnostics for identifying genetic diseases and disorders; genome sequencing services; clinical rapid whole genome sequencing test to enable the prevention, diagnosis and treatment of genetic diseases and disorders; development and commercialization of technology that provides clinical guidance; software platform for data analysis, data management, data storage, data interpretation, and report generation, all in the field of genetics and genetic testing; clinical decision support technology to assist in the translation of complex genomic sequencing for use in treatment plans by healthcare providers

medical diagnostic and treatment services, namely, whole genome sequencing testing for treating of genetic disease and disorders; clinical whole genome sequencing testing to enable the prevention, diagnosis and treatment of genetic diseases and disorders; providing medical screening for detecting genetic diseases in newborns; medical diagnosis, namely, translations of complex genomic sequencing for use in individualized patient treatment plans by healthcare providers for the diagnosis and treatment of genetically-linked diseases and conditions; providing genetic counseling and information services